Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kornelia Polyak, Ph.D., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Kornelia Polyak and Aditya Bardia.
Kornelia Polyak
Connection Strength
0.106
Aditya Bardia
  1. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab. Cancer Discov. 2021 10; 11(10):2474-2487.
    View in: PubMed
    Score: 0.058
  2. Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer. NPJ Breast Cancer. 2018; 4:10.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.